Immediate Impact
10 from Science/Nature 62 standout
Citing Papers
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
2023 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Works of N.K. Edens being referenced
Food intake in diabetic rats: isolation of primary metabolic effects of fat feeding
1985
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| N.K. Edens | 302 | 82 | 44 | 98 | 89 | 12 | 445 | |
| Michèle Dauzats | 372 | 74 | 32 | 167 | 108 | 16 | 508 | |
| Wolfgang Hofmann | 262 | 92 | 26 | 116 | 61 | 8 | 415 | |
| Alena Janovská | 233 | 42 | 68 | 115 | 74 | 13 | 420 | |
| Milada Horáková | 302 | 80 | 56 | 167 | 115 | 16 | 509 | |
| RO Scow | 201 | 72 | 90 | 116 | 39 | 12 | 476 | |
| Matthew Neville | 263 | 27 | 45 | 102 | 176 | 10 | 463 | |
| Laryssa N. Kaufman | 264 | 49 | 50 | 99 | 46 | 15 | 449 | |
| Louise D. Høeg | 308 | 122 | 14 | 168 | 83 | 9 | 444 | |
| Weisheng Xie | 239 | 110 | 100 | 175 | 181 | 9 | 502 | |
| Kerry L. Mullen | 339 | 69 | 43 | 189 | 222 | 10 | 472 |
All Works
Loading papers...